Why Is Ultragenyx (RARE) Up 6.4% Since Last Earnings Report?
Ultragenyx (RARE) reported Q2 2026 earnings that beat expectations with a narrower loss of $0.90 per share versus consensus of $1.27, and revenues of $214 million surged 28.1% year-over-year, marking the company's highest quarterly revenues. However, despite the strong results, estimate revisions have trended downward over the past month, and the stock received a Zacks Rank #3 (Hold) rating with expectations for in-line returns in the coming months.